Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Eye Care

Journal Scan / Research · July 04, 2023

Long-Term Risk of Steroid-Induced Ocular Hypertension or Glaucoma Associated With Topical Prednisolone Acetate 1% Use After DSEK



Additional Info

Disclosure statements are available on the authors' profiles:

Long-Term Risk of Steroid-Induced Ocular Hypertension/Glaucoma With Topical Prednisolone Acetate 1% After Descemet Stripping Endothelial Keratoplasty
Cornea 2023 Jun 07;[EPub Ahead of Print], MO Price, DA Price, FW Price

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading